Furthermore, some cancer cell lines display decreased PERK-mediated eIF2α signaling, suggesting that PERK activation and CHOP expression may attenuate malignant transformation and progression under certain conditions or in a cell type–dependent manner62,65. Here, EIF2AK3 is linked to cancer.